Posted On: 05/23/2014 12:17:15 PM
Post# of 5066
New4This, it's a good find, but isn't owned by BMSN/REGEN.
It's great that this study verifies siRNA technology, but siRNA technology is not totally licensed or owned by REGEN, so it doesn't translate into more pipeline products for REGEN. Regen has licensed from Benitec a specificified target of siRNA technology as I understand it for a specific treatment.
Still, bodes well that if others are having success with siRNA technology, Regen will too. If Regen owned siRNA technology or licensed all applications thereof, the stock price would react to every related piece of news.
It's great that this study verifies siRNA technology, but siRNA technology is not totally licensed or owned by REGEN, so it doesn't translate into more pipeline products for REGEN. Regen has licensed from Benitec a specificified target of siRNA technology as I understand it for a specific treatment.
Still, bodes well that if others are having success with siRNA technology, Regen will too. If Regen owned siRNA technology or licensed all applications thereof, the stock price would react to every related piece of news.
Quote:
Basically, Regen has more in the pipeline!!!
This study verifies that siRNA (an exclusive lisenced product from benitec) is being used to silence rejection of tissues donated from another person, specifically in this study regarding heart transplants. Anti-rejection medicines currently used have extreme side effects and must be taken for life. With siRNA the rejection can be stopped permanently without side effects!!!!
This is huge!!!
Read More: http://investorshangout.com/post/view?id=1541...z32YWqheJs
(0)
(0)Scroll down for more posts ▼
